HomeWINT • NASDAQ
add
Windtree Therapeutics Inc
Previous close
$0.61
Day range
$0.46 - $0.60
Year range
$0.45 - $22.31
Market cap
5.48M USD
Avg Volume
1.90M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 4.74M | 1.09% |
Net income | -2.75M | 37.88% |
Net profit margin | — | — |
Earnings per share | -4.23 | 72.67% |
EBITDA | -4.69M | -0.38% |
Effective tax rate | 8.03% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.30M | -68.77% |
Total assets | 30.45M | -15.56% |
Total liabilities | 26.04M | -8.87% |
Total equity | 4.41M | — |
Shares outstanding | 8.99M | — |
Price to book | 1.24 | — |
Return on assets | -40.07% | — |
Return on capital | -187.10% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -2.75M | 37.88% |
Cash from operations | -6.44M | -67.20% |
Cash from investing | 0.00 | 100.00% |
Cash from financing | 6.94M | 3,078.97% |
Net change in cash | 497.00K | 112.12% |
Free cash flow | 2.68M | 220.99% |
About
Windtree Therapeutics, Inc. is an American company which was set up in 1992 and now is based in Warrington, Pennsylvania, developing drug products for patients with respiratory disease. The company joined an alliance with Laboratorios del Dr. Esteve, S.A. In 2016, Discovery Laboratories changed name to Windtree Therapeutics, Inc. Wikipedia
Founded
Nov 6, 1992
Headquarters
Website
Employees
15
